This annual list awards MedTech companies at the forefront of tackling surgical challenges in the orthopedic industry. Biologica’s core product platform, ProteiOS growth factor, is a soluble protein cocktail derived from the endosteum of allograft bone and contains a collection of growth factors, oxygenating peptides, collagen deposition peptides, and cellular attachment peptides.

“We take immense pride in being named as a Top 10 MedTech startup and the recognition it brings to our ProteiOS technology,” stated Scott Cadotte, Vice President of Sales & Marketing of Biologica Technologies. “It further validates our positioning of ProteiOS and its distinct advantages over current products in the osteobiologic market.”

To view the MedTech Outlook article, visit http://bit.ly/32hiqB8

About Biologica Technologies
Founded in 2015, Biologica Technologies is a company focused on providing clinically relevant biologic solutions across multiple medical specialties. Biologica has developed innovative and ground breaking methods to access the naturally occurring growth factors found within allograft tissue, with ProteiOS growth factor being their first introduction into the orthopaedic and neurosurgery markets. The company is privately-held and headquartered in Carlsbad, CA.

Related Links

www.biologicatechnologies.com

SOURCE Biologica Technologies

Related Links

http://www.biologicatechnologies.com



READ SOURCE

READ  PwC Netherlands Join Efforts with High-Tech Bridge to Provide DevSecOps and CI/CD Application Security Testing - Business Wire

WHAT YOUR THOUGHTS

Please enter your comment!
Please enter your name here